This new molecule, by acting synergistically on combined systems known to be altered in T2DM [33, 34], could indeed expand the therapeutic potential of GLP-1 agonists/analogues, suggesting new scenarios in terms of improving glycemic control, weight management, and hopefully providing protection against chronic micro-macrovascular complications and not only limited to hepatic complications
Its truly a '150 lbs weight loss before and after' experience, not just physically, but mentally too
This approach helps minimize side effects while allowing the body to adjust to the new treatment
The energy boost and mental clarity are next level
How do biguanides, such as metformin, work in managing type 2 diabetes
Association between Genetic Variants of CELSR2-PSRC1-SORT1 and Cardiovascular Diseases: A Systematic Review and Meta-Analysis